NO20001055D0 - Sterilisert 5-aminolevulinsyre - Google Patents
Sterilisert 5-aminolevulinsyreInfo
- Publication number
- NO20001055D0 NO20001055D0 NO20001055A NO20001055A NO20001055D0 NO 20001055 D0 NO20001055 D0 NO 20001055D0 NO 20001055 A NO20001055 A NO 20001055A NO 20001055 A NO20001055 A NO 20001055A NO 20001055 D0 NO20001055 D0 NO 20001055D0
- Authority
- NO
- Norway
- Prior art keywords
- crystals
- ala
- colored
- sterile
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measurement Of Radiation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Radiation-Therapy Devices (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/921,664 US5856566A (en) | 1997-09-02 | 1997-09-02 | Sterilized 5-aminolevulinic acid |
PCT/US1998/018181 WO1999011604A1 (en) | 1997-09-02 | 1998-09-02 | Sterilized 5-aminolevulinic acid |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20001055D0 true NO20001055D0 (no) | 2000-03-01 |
NO20001055L NO20001055L (no) | 2000-04-18 |
NO327985B1 NO327985B1 (no) | 2009-11-02 |
Family
ID=25445779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001055A NO327985B1 (no) | 1997-09-02 | 2000-03-01 | Gule 5-aminolevulinsyrekrystaller, steril losning av disse, steril pakke som inneholder dem, fremgangsmate for fremstilling av og forbedring av krystallene, sett som omfatter krystallene og anvendelse av dem for fremstilling av medikament |
Country Status (14)
Country | Link |
---|---|
US (2) | US5856566A (no) |
EP (1) | EP1007504B1 (no) |
JP (1) | JP2001514243A (no) |
AT (1) | ATE268748T1 (no) |
AU (1) | AU747730B2 (no) |
BR (1) | BR9812164A (no) |
CA (1) | CA2302228C (no) |
DE (1) | DE69824422T2 (no) |
DK (1) | DK1007504T3 (no) |
ES (1) | ES2223140T3 (no) |
NO (1) | NO327985B1 (no) |
NZ (1) | NZ503644A (no) |
PT (1) | PT1007504E (no) |
WO (1) | WO1999011604A1 (no) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856566A (en) * | 1997-09-02 | 1999-01-05 | Dusa Pharmaceuticals, Inc. | Sterilized 5-aminolevulinic acid |
FR2777782B1 (fr) * | 1998-04-22 | 2001-05-18 | Alexandre Marti | Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires |
US6223071B1 (en) * | 1998-05-01 | 2001-04-24 | Dusa Pharmaceuticals Inc. | Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light |
DE19827417B4 (de) * | 1998-06-19 | 2004-10-28 | Hahn, Rainer, Dr.Med.Dent. | Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen |
US6183773B1 (en) | 1999-01-04 | 2001-02-06 | The General Hospital Corporation | Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
KR100365151B1 (ko) * | 2000-05-08 | 2003-02-11 | 김형락 | 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도 |
KR100373147B1 (ko) * | 2000-05-10 | 2003-02-25 | 김형락 | 스쿠치카충 감염증의 치료제 |
DE10034673C1 (de) * | 2000-07-17 | 2002-04-25 | Medac Klinische Spezialpraep | Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung |
CZ295986B6 (cs) * | 2000-07-28 | 2005-12-14 | Science For Life, S. R. O. | Příprava sterilních krystalů kyseliny 5-aminolevulové a jejich derivátů využitelných pro lékařské diagnostické a terapeutické účely |
EP1313448B1 (en) * | 2000-08-16 | 2010-04-07 | The General Hospital Corporation doing business as Massachusetts General Hospital | Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
DE10202487A1 (de) * | 2002-01-23 | 2003-07-31 | Photonamic Gmbh & Co Kg | Dermales Applikationssystem für Aminolävulinsäure-Derivate |
US6913615B2 (en) * | 2002-03-25 | 2005-07-05 | Lumerx, Inc. | Chemiluminescent treatment of acne |
JP2005531336A (ja) * | 2002-04-02 | 2005-10-20 | ルマークス、インコーポレイテッド | 体内の微生物を弱化および/または死滅させるために可視光を用いる装置および方法 |
US7255691B2 (en) * | 2002-04-16 | 2007-08-14 | Lumerx Inc. | Chemiluminescent light source using visible light for biotherapy |
US20050209331A1 (en) * | 2004-03-22 | 2005-09-22 | Syneron Medical Ltd. | Method of treatment of skin |
US20050209330A1 (en) * | 2004-03-22 | 2005-09-22 | Syneron Medical Ltd. | Method of treatment of skin |
US20060094781A1 (en) * | 2004-11-04 | 2006-05-04 | Syneron Medical Ltd. | Method of treating extracellular matrix |
CA2724949A1 (en) | 2007-06-27 | 2008-12-31 | The General Hospital Corporation | Method and apparatus for optical inhibition of photodynamic therapy |
DE102011111865A1 (de) | 2011-08-31 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid |
US9733187B2 (en) * | 2015-03-06 | 2017-08-15 | King Saud University | Method of detecting bladder cancer by optical analysis of bodily fluids |
US10357567B1 (en) | 2018-01-12 | 2019-07-23 | Dusa Pharmaceuticals, Inc. | Methods for photodynamic therapy |
CN109369433B (zh) * | 2018-10-29 | 2020-01-17 | 庄晓青 | 一种f-18标记的5-氨基乙酰丙酸衍生物、合成方法及应用 |
EP3976107A4 (en) * | 2019-05-29 | 2023-10-11 | Sonalasense, Inc. | SOUND SENSITIZATION |
WO2023105290A1 (en) | 2021-12-10 | 2023-06-15 | Insightec, Ltd. | Short-pulse sonodynamic treatment apparatus |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0685024B2 (ja) | 1984-10-26 | 1994-10-26 | オリンパス光学工業株式会社 | 内視鏡装置 |
JPS62111954A (ja) * | 1985-11-09 | 1987-05-22 | Japan Spectroscopic Co | アミノレブリン酸の合成法 |
US5422093A (en) * | 1989-07-28 | 1995-06-06 | Queen's University | Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
US5234940A (en) * | 1989-07-28 | 1993-08-10 | Queen's University | Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
DE4228106A1 (de) | 1992-08-24 | 1994-03-03 | Medac Klinische Spezialpraep | Verwendung von £-Aminolävulinsäure zur Herstellung eines topischen Arzneimittels zur integralen Diagnose und/oder Therapie von Tumoren in Hohlorganen |
WO1994006424A1 (en) * | 1992-09-21 | 1994-03-31 | Quadra Logic Technologies, Inc. | Transcutaneous in vivo activation of photosensitive agents in blood |
JP2997979B2 (ja) * | 1993-01-20 | 2000-01-11 | 株式会社コスモ総合研究所 | 5−アミノレブリン酸の製造方法 |
GB9318841D0 (en) | 1993-09-10 | 1993-10-27 | Res Foundation Of The Norwegia | Composition |
JPH07238063A (ja) * | 1994-02-25 | 1995-09-12 | Cosmo Sogo Kenkyusho:Kk | 5−アミノレブリン酸の回収精製法 |
US5856566A (en) * | 1997-09-02 | 1999-01-05 | Dusa Pharmaceuticals, Inc. | Sterilized 5-aminolevulinic acid |
-
1997
- 1997-09-02 US US08/921,664 patent/US5856566A/en not_active Expired - Lifetime
-
1998
- 1998-09-02 NZ NZ503644A patent/NZ503644A/xx not_active IP Right Cessation
- 1998-09-02 AU AU92155/98A patent/AU747730B2/en not_active Ceased
- 1998-09-02 BR BR9812164-2A patent/BR9812164A/pt not_active Application Discontinuation
- 1998-09-02 AT AT98944666T patent/ATE268748T1/de active
- 1998-09-02 ES ES98944666T patent/ES2223140T3/es not_active Expired - Lifetime
- 1998-09-02 JP JP2000508645A patent/JP2001514243A/ja active Pending
- 1998-09-02 DK DK98944666T patent/DK1007504T3/da active
- 1998-09-02 EP EP98944666A patent/EP1007504B1/en not_active Expired - Lifetime
- 1998-09-02 CA CA2302228A patent/CA2302228C/en not_active Expired - Fee Related
- 1998-09-02 PT PT98944666T patent/PT1007504E/pt unknown
- 1998-09-02 US US09/486,604 patent/US6335465B1/en not_active Expired - Lifetime
- 1998-09-02 WO PCT/US1998/018181 patent/WO1999011604A1/en active IP Right Grant
- 1998-09-02 DE DE69824422T patent/DE69824422T2/de not_active Expired - Lifetime
-
2000
- 2000-03-01 NO NO20001055A patent/NO327985B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20001055L (no) | 2000-04-18 |
NO327985B1 (no) | 2009-11-02 |
WO1999011604A9 (en) | 1999-07-08 |
EP1007504A1 (en) | 2000-06-14 |
ATE268748T1 (de) | 2004-06-15 |
DE69824422D1 (de) | 2004-07-15 |
EP1007504B1 (en) | 2004-06-09 |
US5856566A (en) | 1999-01-05 |
ES2223140T3 (es) | 2005-02-16 |
AU9215598A (en) | 1999-03-22 |
US6335465B1 (en) | 2002-01-01 |
CA2302228A1 (en) | 1999-03-11 |
BR9812164A (pt) | 2000-07-18 |
DK1007504T3 (da) | 2004-10-25 |
DE69824422T2 (de) | 2005-06-09 |
WO1999011604A1 (en) | 1999-03-11 |
NZ503644A (en) | 2002-09-27 |
CA2302228C (en) | 2011-10-25 |
JP2001514243A (ja) | 2001-09-11 |
AU747730B2 (en) | 2002-05-23 |
PT1007504E (pt) | 2004-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1007504T3 (da) | Steriliseret 5-aminolevulinsyre | |
BR0315088A (pt) | Métodos para produção de um efeito antiangiogênico e/ou redutor de permeabilidade vascular em um animal de sangue quente e para tratamento de câncer em um animal de sangue quente, composição farmacêutica, kit, e, uso de zd6474 ou de um sal fermaceuticamento aceitável do mesmo e gencitabina | |
ID22689A (id) | Metode untuk mengaktifkan sel-sel yang menunjukan-sifat antigen manusia, sel-sel teraktifkan yang menunjukan sifat antigen manusia, dan penggunaannya | |
ES8200082A1 (es) | Procedimiento para esterilizar un agente de contraste de ra-yos x de m-carboxamido-o-yodo-n-(b-hidroxialcohil)-anilina. | |
HU9202227D0 (en) | Method for producing triazolo-pyrimidine derivatives and pharmaceutical preparatives containing said compounds | |
BR0014895A (pt) | Formulação lìquida estável, processo para a preparação da mesma, uso da mesma, uso de polietileno glicol e sal de sódio ou potássio de um inibidor h+, k+-atpase, e, método para tratar doenças gastrointestinais | |
DE3162614D1 (en) | Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same | |
CA2270558A1 (en) | Treatment of autoimmune diseases by photochemotherapy | |
RU92003144A (ru) | Способ предотвращения деполимеризации растворов гиалуроновой кислоты при стерилизации ионизирующей радиацией | |
IT983092B (it) | Processo per la produzione di ele menti di conduzione in tessuto umano o animale per il ripristino di parti specifiche danneggiate o distrutte di tessuto nel corpo uma no e di animali | |
GB2120529A (en) | Methods of preparing and using intravenous nutrient compositions | |
NO910033D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser. | |
ES2196165T3 (es) | Terapia de citoxina activada por radiacion. | |
RU2123364C1 (ru) | Способ и устройство для лечения воспалительных процессов | |
EP0424667B1 (en) | A salt restored from discoloration and a method for this restoration | |
KR20210121826A (ko) | 과산화수소를 산화반응시켜 발생한 물질을 당류와 혼재시켜 암조직에 주사하여 암세포를 괴사시키는 시스템 | |
HUT45989A (en) | Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing them as active substance | |
RU2104723C1 (ru) | Способ воздействия на биологический объект световым потоком и устройство для его осуществления | |
ATE12649T1 (de) | Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate. | |
Gomer et al. | Examination of potentially lethal damage in cells treated with hematoporphyrin derivative and red light | |
RU93039070A (ru) | Способ лечения больных местно-распространенными формами рака | |
RU93054019A (ru) | Устройство для ультрафиолетового облучения крови | |
RU93057297A (ru) | Способ лечения лиц, получивших облучение малыми дозами ионизирующей радиации с хроническим фарингитом в сочетании с астено-невротическим синдромом | |
RU94043935A (ru) | Способ сокращения сроков лечения различных болезней человека и животных | |
RU93030638A (ru) | Способ лечения остеоартроза у больных, подвергшихся влиянию малых доз ионизирующего излучения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |